- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00159575
Metformin in Assisted Reproduction-MET-AR-study
Metformin Treatment Before IVF / ICSI in Non-obese Women With Polycystic Ovarian Syndrome
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
PCOS is an hormonal disease including hyperandrogenism, oligo-or anovulation and/or polycystic ovaries by ultrasound. PCOS women often suffer insulin resistance or even diabetes risk as well as a full blown metabolic disease.
These women often suffer infertility due to their lack of regular ovulations. Metformin is a well known anti-diabetic drug, and in some PCOS women metformin might decrease the hyperandrogenism, improve insulin resistance and give more regular ovulations. Thereby increase chance of pregnancy. Our hypothesis is that metformin will increase clinical pregnancy rates both spontaneously and following IVF/ICSI.
Study Type
Enrollment (Actual)
Phase
- Phase 4
Contacts and Locations
Study Locations
-
-
-
Trondheim, Norway, 7006
- Sigrun Kjøtrød
-
Trondheim, Norway, 7046
- Fertility UNit- -St Olavs Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Fulfilling Rotterdam criteria for PCOS
- Infertility more than 1 year
- First or second cycle of IVF/ICSI treatment
- Age below 38 years at inclusion
- BMI below 28 kg/m3 at inclusion
- Willing to be randomised to 4 months metformin or placebo
- Signed written informed consent
Exclusion Criteria:
- Not suitable for starting dose 112.5 IE
- Basal FSH above 10 IU/L
- Known renal disease or s-creatinine above 110 umol/L
- Known liver disease or s-ALAT above 80 IU/L
- Known alcoholism or drug abuse
- Known diabetes mellitus or fasting plasma glucose above 7 mmol/L
- Corticosteroid treatment (oral)
- Treatment with cimetidine, anticoagulants, erythromycin or other macrolides
- Hyperprolactinemia (PRL above 700 mIU/L)
- Abnormal thyroid function tests
- Known congenital adrenal hyperplasia
- Androgen secreting tumours
- Cushing syndrome
- Metformin treatment within the last one month prior to screening
- Unfit to participate for any other reason
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: M: Metformin P: Placebo
|
M: Metformin 2000mg daily- 12-14 weeks of pretreatment + metformin 2000mg daily through conventional IVF ending on the day of pregnancy test; IE. 14 days after embryo transfer.
P: Or identical placebo treatment for the same period
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
To investigate whether four months of Metformin treatment before IVF (in-vitro-fertilisation) or ICSI (intra-cytoplasmic sperm injection) will increase clinical pregnancy rate in normal weight PCOS-women
Time Frame: Vaginal ultrasound in pregnancy week 7
|
Vaginal ultrasound in pregnancy week 7
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Spontaneous pregnancy rates during the pretreatment period, Spontaneous abortion rates (I or II trim.abortions), Live birth rates,
Time Frame: Vaginal ultrasound in pregnancy week 7
|
Vaginal ultrasound in pregnancy week 7
|
Number of oocytes collected, Embryo quality, Number of days of gonadotrophin treatment, Dose of gonadotrophin, total per cycle and daily, s-estradiol on day of hCG-administration, Occurrence of ovarian hyperstimulation syndrome (OHSS)
Time Frame: All data evaluated at study end, from september 2009 onwards
|
All data evaluated at study end, from september 2009 onwards
|
Collaborators and Investigators
Investigators
- Study Chair: Sven Carlsen, MD,PhD, St Olavs Hospital- Endocrinological section
Publications and helpful links
General Publications
- Tso LO, Costello MF, Albuquerque LET, Andriolo RB, Macedo CR. Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome. Cochrane Database Syst Rev. 2020 Dec 21;12(12):CD006105. doi: 10.1002/14651858.CD006105.pub4.
- Kjotrod SB, Carlsen SM, Rasmussen PE, Holst-Larsen T, Mellembakken J, Thurin-Kjellberg A, Haapaniemikouru K, Morin-Papunen L, Humaidan P, Sunde A, von During V. Use of metformin before and during assisted reproductive technology in non-obese young infertile women with polycystic ovary syndrome: a prospective, randomized, double-blind, multi-centre study. Hum Reprod. 2011 Aug;26(8):2045-53. doi: 10.1093/humrep/der154. Epub 2011 May 23.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- MET-AR study -PCOS 5
- EUDRACTNR. 2004-001124-20
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Polycystic Ovary Syndrome
-
Cairo UniversityCompleted
-
Alexandria UniversityRecruitingPolycystic Ovary Syndrome (PCOS)Egypt
-
Saudi German Hospital - MadinahCompletedPolycystic Ovary Syndrome (PCOS)Saudi Arabia
-
University of CopenhagenCompletedPolycystic Ovary Syndrome (PCOS)Denmark
-
Odense University HospitalCompleted
-
Poznan University of Medical SciencesUniversity of California, DavisUnknownPolycystic Ovary Syndrome (PCOS)Poland
-
Assaf-Harofeh Medical CenterUnknownInfertility | Polycystic OvariesIsrael
-
Mansoura UniversityNot yet recruitingPCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries
-
Riphah International UniversityCompleted
-
Dexa Medica GroupCompletedPolycystic Ovary Syndrome (PCOS)Indonesia
Clinical Trials on Metformin / Placebo treatment for 4 months
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI)Completed
-
University Hospital, GrenobleCompletedHeart Failure | Central Sleep Apneas Syndrome | Coronary Artery Bypass Graft Surgery or Other Coronary ReperfusionFrance
-
Xiang Guang-daUnknownAging | Metformin | Overweight SubjectsChina
-
All India Institute of Medical Sciences, New DelhiSanjay Gandhi Postgraduate Institute of Medical Sciences; Christian Medical...Completed
-
Washington University School of MedicineVarian Medical SystemsCompletedNon-Small Cell Lung Cancer | Nonsmall Cell Lung Cancer | Carcinoma, Non-Small-Cell-LungUnited States
-
Kristian KarstoftUniversity of CopenhagenCompletedDiabetes Mellitus, Type 2 | Impaired Glucose ToleranceDenmark
-
Kristian KarstoftUniversity of CopenhagenCompletedDiabetes Mellitus, Type 2 | Impaired Glucose ToleranceDenmark
-
Agios Pharmaceuticals, Inc.CompletedHealthy VolunteersUnited States
-
Centre for Addiction and Mental HealthEnrolling by invitationBorderline Personality Disorder | Suicide and Self-harmCanada
-
University of PennsylvaniaPennsylvania Department of HealthCompleted